Healthcare -
Biotechnology - NASDAQ - US
$ 8.3
0.606 %
$ 410 M
Market Cap
-2.26
P/E
KALV - SHORT-TERM INVESTMENTS
Short-term Investments KALV - KalVista Pharmaceuticals, Inc.
179 M
LAST VALUE
14.82%
2 YEAR CAGR
21.02%
5 YEAR CAGR
0.00%
10 YEAR CAGR